AMRX: Multiplikator P/S Amneal Pharmaceuticals Inc

Simbol lan logo merek Amneal Pharmaceuticals, Inc. (AMRX)

Amneal Pharmaceuticals focuses on the production of biosimilars and Parkinson's disease therapies to drive profit growth. Business scalability relies on massive FDA-approved plant capacities that reduce production costs. Cost optimization is achieved through flexible outsourcing of clinical trials. On GURU.Markets, the change in the price-to-sales ratio demonstrates the market valuation of the asset, where the current level of the metric is 2.30.

AMRX Amneal Pharmaceuticals, Inc.: Rasio rega marang pendapatan ing interval 04.07.2022 - 16.11.2026

Rincian analitis perusahaan Amneal Corp (AMRX)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:Amneal Pharmaceuticals Inc AMRX
Produk seri Amneal Pharmaceuticals Inc

To assess long-term overpayment risks for the investor, it is essential to analyze the P/S ratio—the relationship between market capitalization and annual revenue—which determines the cost of every dollar of sales for Amneal Pharmaceuticals (AMRX). The historical P/S level on the GURU.Markets platform reflects the balance between market expectations and the company's actual growth in the complex generics and biosimilars segment while maintaining high portfolio margins.

Karo sapa Amneal Pharmaceuticals saingan

HLN (Haleon) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Kenvue Inc KVUE|Verona Pharma Corp - Rasio rega marang pendapatan|MENS: Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan Ligand Pharmaceuticals LGND|Perrigo (PRGO) - Rasio rega marang pendapatan|ALVO (Alvotech S.A.) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan LQDA|Multiplikator P/S Galapagos Corp|Rasio rega marang pendapatan ANI Pharma (ANIP)|Multiplikator P/S MannKind Corporation (MNKD)|Rasio rega marang pendapatan Amphastar Pharmaceuticals Inc AMPH|Multiplikator P/S Pacira PCRX|ARS Pharmaceuticals Inc - Multiplikator P/S|TBPH - Multiplikator P/S|AQST (Aquestive Therapeutics) - Kapitalisasi marang pendapatan|scPharmaceuticals, Inc. (SCPH) - Multiplikator P/S|Kapitalisasi marang pendapatan TECX|Multiplikator P/S Tonix Pharma|Kapitalisasi marang pendapatan SXTC (SXT Pharmaceuticals)|EPRX: Rasio rega marang dodolan|BioHarvest Sciences - Kapitalisasi marang pendapatan|EXOZ: Rasio kapitalisasi marang pendapatan|ORMP - Rasio rega marang pendapatan|ENTX: Rasio rega marang pendapatan|HYFT: Multiplikator P/S|Kapitalisasi marang pendapatan ABVC BioPharma Inc|CPIX (Cumberland Corp) - Multiplikator P/S|Multiplikator P/S quantumbiopharma.com|Multiplikator P/S FGEN|Kapitalisasi marang pendapatan Telomir Pharmaceuticals, Inc. TELO|Multiplikator P/S RANI (Rani Therapeutics)|SNYR (Synergy CHC Corp) - Rasio rega marang dodolan|RLYB: Kapitalisasi marang pendapatan|lexariabioscience.com (LEXX) - Kapitalisasi marang pendapatan|Pulmatrix Inc (PULM) - Rasio rega marang pendapatan|PTHL: Kapitalisasi marang volume dodolan|APM (Aptorum Group Ltd) - Multiplikator P/S|Lyra Therapeutics Inc (LYRA) - Koefisien rega marang pendapatan|Multiplikator P/S IBO|Kapitalisasi marang volume dodolan TNFA|cbdMD, Inc. - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan PRFX|Altamira Therapeutics Ltd. - Multiplikator P/S|LIPO: Rasio rega marang pendapatan|OPTN: Multiplikator P/S|Rasio rega marang dodolan PIRS (Pieris Pharmaceuticals)|PROC (Procaps) - Multiplikator P/S|PTPI (Petros Pharmaceuticals Inc) - Kapitalisasi marang volume dodolan|Multiplikator P/S QLI|SLRN - Rega marang dodolan|Multiplikator P/S TFFP (TFF Pharmaceuticals, Inc)